MedPath

Clinical Study of Yishen Granule Combined with Warm Acupuncture in the Treatment of Myelosuppression of Lung Cancer after Chemotherapy

Not Applicable
Recruiting
Conditions
Cancer
Registration Number
ITMCTR2000003140
Lead Sponsor
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Shanghai University of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients with lung cancer diagnosed by pathology or cytology;
2. Chemotherapy was completed, and I~III degree myelosuppression occurred more than once during the first to the last period of chemotherapy;
3. The estimated survival time is more than 3 months;
4. The ECOG score of physical condition is less than 2;
5. Aged 18 to 74 years;
6. Voluntary participate in the study and signed the informed consent form.

Exclusion Criteria

1. With histories of hypersplenism, hematopathy or other malignant tumors;
2. With serious or uncontrolled medical diseases and infected persons;
3. Those who have received hematopoietic stem cell transplantation or bone marrow transplantation;
4. People with traumatic skin, unsuitable for acupuncture or allergic to aiyan;
5. People who are participating in other clinical studies or have participated in other clinical studies within one month.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes of white blood cell count, neutrophil count, hemoglobin and platelet count;
Secondary Outcome Measures
NameTimeMethod
Quality of life score;score of physical condition (ECOG);
© Copyright 2025. All Rights Reserved by MedPath